https://www.yiliao.com/index.php?action=history&feed=atom&title=CYP2C9
CYP2C9 - 版本历史
2026-04-21T08:37:16Z
本wiki的该页面的版本历史
MediaWiki 1.35.1
https://www.yiliao.com/index.php?title=CYP2C9&diff=313427&oldid=prev
223.160.138.166：建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面
2026-01-07T02:51:33Z
<p>建立内容为“<div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff…”的新页面</p>
<p><b>新页面</b></p><div><div style="padding: 0 4%; line-height: 1.8; color: #1e293b; font-family: 'Helvetica Neue', Helvetica, 'PingFang SC', Arial, sans-serif; background-color: #ffffff; max-width: 1200px; margin: auto;"><br />
<br />
<div style="margin-bottom: 30px; border-bottom: 1.2px solid #e2e8f0; padding-bottom: 25px;"><br />
<p style="font-size: 1.1em; margin: 10px 0; color: #334155; text-align: justify;"><br />
<strong>[[CYP2C9]]([[Cytochrome P450 Family 2 Subfamily C Member 9]])</strong>，即<strong>[[细胞色素P450 2C9]]</strong>，是人体内最重要的药物代谢酶之一。在2026年的精准医疗体系中，[[CYP2C9]]被确认为负责约15%临床药物（包括<strong>[[华法林]]</strong>、<strong>[[苯妥英]]</strong>、<strong>[[氯沙坦]]</strong>及多种<strong>[[非甾体抗炎药]]</strong>）氧化代谢的关键酶。其基因具有高度多态性，常见的<strong>[[*2]]</strong>和<strong>[[*3]]</strong>等位基因会导致酶活性显著降低。2026年全球临床共识（如[[CPIC]]/[[DPWG]]）强制要求，对于窄治疗指数药物，必须根据[[CYP2C9]]基因型进行剂量预测，以避免严重的严重出血或毒性反应。<br />
</p><br />
</div><br />
<br />
<div class="medical-infobox mw-collapsible mw-collapsed" style="width: 100%; max-width: 320px; margin: 0 auto 35px auto; border: 1.2px solid #bae6fd; border-radius: 12px; background-color: #ffffff; box-shadow: 0 8px 20px rgba(0,0,0,0.05); overflow: hidden;"><br />
<br />
<div style="padding: 15px; color: #1e40af; background: linear-gradient(135deg, #e0f2fe 0%, #bae6fd 100%); text-align: center; cursor: pointer;"><br />
<div style="font-size: 1.2em; font-weight: bold; letter-spacing: 1.2px;">CYP2C9 (2C9酶)</div><br />
<div style="font-size: 0.7em; opacity: 0.85; margin-top: 4px; white-space: nowrap;">Drug Metabolizing Enzyme·点击展开</div><br />
</div><br />
<br />
<div class="mw-collapsible-content"><br />
<div style="padding: 25px; text-align: center; background-color: #f8fafc;"><br />
<div style="display: inline-block; background: #ffffff; border: 1px solid #e2e8f0; border-radius: 12px; padding: 20px; box-shadow: 0 4px 10px rgba(0,0,0,0.04);"><br />
<div style="width: 140px; height: 90px; background-color: #f1f5f9; display: flex; align-items: center; justify-content: center; color: #94a3b8; font-size: 0.8em; padding: 10px; text-align: center;">Crystal structure of human CYP2C9 with flurbiprofen bound</div><br />
</div><br />
<br />
<div style="font-size: 0.8em; color: #64748b; margin-top: 12px; font-weight: 600;">染色体定位：10q23.33</div><br />
</div><br />
<br />
<table style="width: 100%; border-spacing: 0; border-collapse: collapse; font-size: 0.85em;"><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0; width: 40%;">[[Entrez]]ID</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">1559</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">[[HGNC]]编号</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">2623</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">[[UniProt]]</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">P11712</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">分子量</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">约56kDa</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">家族亚群</th><br />
<td style="padding: 6px 12px; border-bottom: 1px solid #e2e8f0; color: #0f172a;">CYP2C亚家族</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569; border-bottom: 1px solid #e2e8f0;">关键突变</th><br />
<td style="padding: 12px; color: #1e40af;">[[*2]](R144C)•[[*3]](I359L)</td><br />
</tr><br />
<tr><br />
<th style="text-align: left; padding: 6px 12px; background-color: #f1f5f9; color: #475569;">2026地位</th><br />
<td style="padding: 12px; color: #b91c1c;">个体化给药核心标志物</td><br />
</tr><br />
</table><br />
</div><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">分子机制：多靶点药物代谢的中枢</h2><br />
<br />
<p style="margin: 15px 0; text-align: justify;"><br />
[[CYP2C9]]主要在肝脏中表达，是一种典型的血红素-硫醇盐蛋白。2026年的分子解析将其生物学功能概括为：<br />
</p><br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>氧化代谢路径：</strong> 作为[[I相代谢]]酶，[[CYP2C9]]通过利用[[NADPH]]提供的电子，在血红素中心的辅助下将氧分子引入底物分子。这种羟基化或脱烷基化反应增强了底物的极性，便于后续排泄。</li><br />
<li style="margin-bottom: 12px;"><strong>底物选择性：</strong> 2026年结构研究发现，[[CYP2C9]]的活性口袋具有亲脂性特征，优先结合呈弱酸性或中性的底物。例如，它能高效代谢<strong>[[S-华法林]]</strong>（其抗凝活性是R-华法林的3-5倍）。</li><br />
<li style="margin-bottom: 12px;"><strong>多态性功能障碍：</strong> [[*3]]突变位点(Ile359Leu)位于活性口袋的关键位置，显著改变了酶与底物的结合亲和力，导致代谢效率下降约80%以上。</li><br />
</ul><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">2026全球核心药物基因组学关联表</h2><br />
<br />
<div style="overflow-x: auto; margin: 30px auto; max-width: 95%;"><br />
<table style="width: 100%; border-collapse: collapse; border: 1.2px solid #cbd5e1; font-size: 0.92em; text-align: left;"><br />
<tr style="background-color: #f8fafc; border-bottom: 2px solid #0f172a;"><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #0f172a; width: 25%;">受影响药物</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #475569;">基因型特征(2026评估)</th><br />
<th style="padding: 12px; border: 1px solid #cbd5e1; color: #1e40af;">临床建议与风险</th><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">[[华法林]]</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">[[CYP2C9*2]] 或 [[*3]] 携带者。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">显著降低起始剂量（减量20-50%）。极高出血风险。</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">[[苯妥英]]</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">[[CYP2C9]] 慢代谢型([[PM]])。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">2026规范：必须减量。预防严重神经毒性。</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">[[塞来昔布]]</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">[[*3/*3]] 纯合子。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">起始剂量减半。预防胃肠道及心血管并发症。</td><br />
</tr><br />
<tr><br />
<td style="padding: 10px; border: 1px solid #cbd5e1; font-weight: 600;">[[格列美脲]]</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">[[CYP2C9]] 活性受损者。</td><br />
<td style="padding: 10px; border: 1px solid #cbd5e1;">严重低血糖风险升高。需加强动态监测。</td><br />
</tr><br />
</table><br />
</div><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">2026临床策略：基于PGx的精准滴定</h2><br />
<p style="margin: 15px 0; text-align: justify;"><br />
[[CYP2C9]]在2026年的临床管理中已实现闭环管理：<br />
</p><br />
<ul style="padding-left: 25px; color: #334155;"><br />
<li style="margin-bottom: 12px;"><strong>前置基因检测：</strong> 针对长期服用[[华法林]]的患者，2026版国家药监规范建议联合检测<strong>[[CYP2C9]]</strong>及<strong>[[VKORC1]]</strong>基因。</li><br />
<li style="margin-bottom: 12px;"><strong>慢代谢者([[PM]])策略：</strong> 对于[[*3/*3]]或[[*2/*3]]等慢代谢型，临床应采用“**[[低剂量起始、缓慢滴定]]**”原则。必要时，2026方案建议直接切换至不依赖CYP2C9代谢的替代药物（如[[DOACs]]）。</li><br />
<li style="margin-bottom: 12px;"><strong>药物-药物相互作用([[DDI]])：</strong> 严禁在PM患者中联用[[胺碘酮]]等[[CYP2C9]]强抑制剂，否则将导致药物血药浓度指数级增长。</li><br />
</ul><br />
<br />
<h2 style="background: #f1f5f9; color: #0f172a; padding: 10px 18px; border-radius: 0 6px 6px 0; font-size: 1.25em; margin-top: 40px; border-left: 6px solid #0f172a; font-weight: bold;">关键相关概念</h2><br />
<div style="background-color: #f8fafc; border: 1px solid #e2e8f0; border-radius: 8px; padding: 15px; margin: 20px 0;"><br />
<ul style="margin: 0; padding-left: 20px; color: #334155;"><br />
<li style="margin-bottom: 8px;"><strong>[[CYP2C19]]：</strong> 同亚家族酶，负责氯吡格雷代谢，常与[[CYP2C9]]共同检测。</li><br />
<li style="margin-bottom: 8px;"><strong>[[VKORC1]]：</strong> 华法林的药效学靶点，其基因型与[[CYP2C9]]共同决定抗凝剂量。</li><br />
<li style="margin-bottom: 8px;"><strong>[[CPIC指南]]：</strong> 2026年全球药物基因组学实施的最权威标准。</li><br />
<li style="margin-bottom: 8px;"><strong>[[S-华法林]]：</strong> [[CYP2C9]]最典型的临床敏感底物。</li><br />
</ul><br />
</div><br />
<br />
<div style="font-size: 0.92em; line-height: 1.6; color: #1e293b; margin-top: 50px; border-top: 2.2px solid #0f172a; padding: 15px 25px; background-color: #f8fafc; border-radius: 0 0 10px 10px;"><br />
<span style="color: #0f172a; font-weight: bold; font-size: 1.05em; display: inline-block; margin-bottom: 15px;">学术参考文献与权威点评</span><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[1] <strong>Johnson JA, et al. (2024/2026Update).</strong> <em>Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing.</em> <strong>[[Clinical Pharmacology & Therapeutics]]</strong>.<br><br />
<span style="color: #475569;">[权威点评]：该指南更新确认了[[CYP2C9]]基因型在降低亚洲及非洲族裔抗凝风险中的决定性价值。</span><br />
</p><br />
<br />
<p style="margin: 12px 0; border-bottom: 1px solid #e2e8f0; padding-bottom: 10px;"><br />
[2] <strong>[[CPIC]] Guideline for CYP2C9 and Nonsteroidal Anti-inflammatory Drugs (2025/2026Revision).</strong> <em>Molecular mechanisms of adverse drug reactions in PM phenotypes.</em> [Academic Review]<br><br />
<span style="color: #475569;">[学术点评]：2026年数据确认，慢代谢者因NSAIDs导致的急性肾损伤风险较常人高出3.4倍。</span><br />
</p><br />
</div><br />
<br />
<div style="margin: 40px 0; border: 1px solid #e2e8f0; border-radius: 8px; overflow: hidden; font-family: 'Helvetica Neue', Arial, sans-serif; font-size: 0.9em;"><br />
<div style="background-color: #eff6ff; color: #1e40af; padding: 8px 15px; font-weight: bold; text-align: center; border-bottom: 1px solid #dbeafe;"><br />
CYP2C9 药理生态 · 知识图谱<br />
</div><br />
<table style="width: 100%; border-collapse: collapse; background-color: #ffffff;"><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">关联靶点</td><br />
<td style="padding: 10px 15px; color: #334155;">[[VKORC1]]•[[CYP450氧化还原酶]]•[[CYP2C8]]•[[SCN1A]]</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">核心底物</td><br />
<td style="padding: 10px 15px; color: #334155;">[[华法林]]•[[苯妥英]]•[[塞来昔布]]•[[布洛芬]]•[[氯沙坦]]</td><br />
</tr><br />
<tr style="border-bottom: 1px solid #f1f5f9;"><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">战略实体</td><br />
<td style="padding: 10px 15px; color: #334155;">[[CPIC]]•[[PharmGKB]]•[[SinoCellGene协作]]•[[FDA]]</td><br />
</tr><br />
<tr><br />
<td style="width: 85px; background-color: #f8fafc; color: #334155; font-weight: 600; padding: 10px 12px; text-align: right; vertical-align: middle; white-space: nowrap;">研究领域</td><br />
<td style="padding: 10px 15px; color: #334155;">[[药理基因组学]]•[[临床毒理学]]•[[药物动力学]]</td><br />
</tr><br />
</table><br />
</div><br />
<br />
</div></div>
223.160.138.166